Cataract Panel
New York
Approved
Genes
Conditions
- Branchiooculofacial Syndrome
- Chanarin-Dorfman syndrome
- Cataract 21
- Cataract 30
- Cataract 36
- Cataract 40
- Cataract 41
- Cataract 43
- Cataract 45
- Cataract 5
- Familial Exudative Vitreoretinopathy
- Galactokinase deficiency
- Galactosemia
- Hereditary Spastic Paraplegia (HSP)
- Lowe Syndrome (Oculocerebrorenal syndrome of Lowe)
- Norrie Disease
- Stickler syndrome
- Axenfeld-Rieger Syndrome
- Rhizomelic chondrodysplasia punctata (RCDP)
- Cerebrotendinous xanthomatosis (CTX)
- Hypomyelination and Congenital Cataract (HCC)
- Cataract
- Marshall syndrome
- Cutis Laxa
Clinical Utility
- Cataracts that are not age-related
- Cataracts co-occurring with other symptoms
- Microopthalmia and glaucoma commonly co-occur.
- Additional eye findings may suggest a syndrome
- Sporadic or familial inheritance patterns
Lab Method
- Next-Gen Sequencing
- Deletion/Duplication Analysis
Test Code
J958
CPT Codes*
81403x1, 81404x1, 81405x2, 81406x2, 81408x1, 81479x3
ABN Required
No
Turnaround Time**
4 weeks
Preferred Specimen
Alternative Specimen
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.
Test Documents
Billing
Targeted Variant Testing